In April 2014, the Guangdong High Court of China published its October 2013 judgments in two Huawei Technologies v. InterDigital cases. One held that U.S.-based InterDigital (IDC) abused its dominant market position by refusing to license standard essential patents (SEPs) for 3G wireless communication devices on fair, reasonable and non-discriminatory (FRAND) terms. The other set a FRAND rate capped at 0.019 percent of the actual product selling price for IDC to license its Chinese SEPs to Huawei.
IDC designs and develops advanced technologies for wireless communications, and has participated in the formulation of international wireless communications standards for which it owns relevant patents. In July 2011, IDC filed patent infringement litigation against Huawei in the U.S. International Trade Commission and in a U.S. District Court. Huawei then sued IDC in December 2011 in the Shenzhen Intermediate People’s Court by filing two complaints, one over an antitrust dispute and one over a FRAND rate dispute. Read More
On April 14, 2014, the Ministry of Commerce (MOFCOM) of the People’s Republic of China filed an amicus brief in In re Vitamin C Antitrust Litigation, No. 13-4791-cv (2d Cir.), arguing that the district court erred in refusing to apply the foreign sovereign compulsion defense to protect Chinese companies sued in the litigation.
In the Vitamin C class action, plaintiffs alleged that several Chinese companies fixed the price of Vitamin C that was exported to the United States. The case was tried in early 2013, and all but two of the defendants settled before the jury rendered its verdict. The jury entered a verdict for plaintiffs in the amount of $54.1 million, which was trebled to $162.3 million before credits for settlements with other defendants. The trial defendants appealed on various grounds. Read More
On May 29, 2014, China’s National Development and Reform Commission (NDRC) announced that its investigation into the eyeglass industry found that some major manufacturers had restricted resale prices, and it therefore instructed local pricing departments in Beijing, Shanghai and Guangdong to impose total fines totaling more than RMB 19 million ($3 million) under the Anti-Monopoly Law. The conduct at issue involved sales contracts requesting distributors to sell products strictly at “suggested retail prices,” or forcing “buy three get one free” (for contact lenses) promotional activity throughout the year. Companies that voluntarily reported to the NDRC and provided important evidence were exempted from any fines. Companies that offered satisfactory cooperation with the investigation and undertook voluntary correction were fined 1 percent of sales revenue of the previous year’s sales. The harshest penalty—a fine of 2 percent of sales revenue for the previous year’s sales—was imposed on companies that undertook voluntary correction, but also could exercise power in controlling prices or did not provide satisfactory cooperation.
The NDRC’s announcement is available here.
On March 18, 2014, the Japan Fair Trade Commission (JFTC) announced it had fined four marine transport companies a total of 22,718,480,000 JPY ($227 million) for engaging in price-fixing activities and violating the Japanese Antimonopoly Act. The JFTC’s action followed the cease and desist and surcharge payment orders that had been issued on Jan. 9, 2014. The fined companies are Nippon Yusen Kabushiki Kaisha, Kawasaki Kisen Kaisha, Ltd., Wallenius Wilhelmsen Logistics, AS and Nissan Motor Car Carrier Co., Ltd. Another subject of the investigation was Mitsui O.S.K. Lines, Ltd., but the company applied for leniency and was exempted from the administrative order and fine. According to the JFTC announcement, the violations included fixing freight rates, colluding to maintain the freight rate, and refraining from bidding against one another from January 2008 to September 2012 with regard to automobile shipments from Japan to North America, Europe and elsewhere.
The JFTC’s announcement can be found here.
The Shanghai High People’s Court recently made available its Aug. 1, 2013 final judgment overruling the Shanghai First Intermediate Court’s judgment in a case brought by a domestic medical distributor, Beijing Rainbow Medical Equipment Technology & Trading Company (Rainbow) against Johnson & Johnson’s (J&J) China operations. The court ruled that J&J’s resale price maintenance (RPM) constitutes a monopolistic agreement, and ordered J&J to indemnify Rainbow’s economic losses of RMB 530,000 ($87,500).
On Jan. 2, 2008, J&J and Rainbow signed a distribution agreement, providing that Rainbow had the authorized right to sell J&J’s Ethicon surgical sutures in Beijing. According to the agreement, Rainbow could not sell Ethicon surgical sutures at a price lower than that stipulated by J&J. In March 2008, Rainbow won a bid to supply surgical sutures to Peking University People’s Hospital by offering a price lower than the one provided in the agreement. On July 1, 2008, J&J issued a letter to Rainbow on deduction of a deposit of RMB 20,000 ($3,245) and cancellation of Rainbow’s sales right in two hospitals in Beijing. The key issue in this case was whether the RPM agreement constitutes a monopolistic agreement under the Antimonopoly Law of the People’s Republic of China (the AML). Read More
In order to specify the applicable standards for simple cases of concentration-of–business-operators, the Ministry of Commence of the People’s Republic of China (MOFCOM) put into effect a simplified merger review system as of Feb. 12, 2014, by publishing the Interim Provisions for Standards of Simple Cases Related to Concentration of Business Operators (the Interim Provisions).
The Interim Provisions set out the thresholds of merger fillings in the simple-case category, which apply under the following circumstances: Read More
On Dec. 16, 2013, the Guangdong provincial Administration for Industry and Commerce (AIC) issued a Written Decision of Administrative Penalty to penalize Huizhou Daya Bay Yiyuan Purified Water (Huizhou) for abuse of dominance through bundled sales.
After concluding that Huizhou has a dominant market position, Guangdong AIC determined that the company conducted bundled sales through the following activities: (1) It required some real estate companies (the Complainants) to sign water supply engineering agreements that contain not only terms for temporary water supply service to construction sites, but also terms requiring the Complainants to engage Huizhou to work on the residential water meter projects; (2) In situations where some real estate companies were firmly opposed, Huizhou agreed to sign water supply engineering agreements without terms for residential water meter projects, but required them to sign a letter promising in the future to sign agreements with Huizhou for residential water meter projects and acknowledging Huizhou’s right to cut water supply in case of a breach of the promise letter; and (3) Huizhou also required Complainants to sign bundled agreements with a third party in areas where Huizhou is not qualified to sign such agreements. Read More
The Shaanxi High People’s Court has formally issued its Sept. 12, 2013 verdict overturning the first instance judgment of a Xi’an Intermediate People’s Court ruling that Shaanxi Broadcast and TV Network Media’s (Shaanxi) sales of its cable TV services to a consumer did not constitute bundled sales in violation of the Antimonopoly Law of the People’s Republic of China (AML).
In May 2012, Shaanxi charged a consumer RMB 30 yuan per month ($5) for cable TV service, a five-yuan increase from the previous monthly rate. According to Shaanxi, the increased fee includes a RMB 15 yuan ($3) fee for the value-added cable services sold together with the basic cable TV services. The consumer plaintiff filed a claim in the first instance court, Xi’an Intermediate People’s Court, asserting that Shaanxi abused its dominant market position by selling bundled cable TV services without reasonable justification. He requested that the court: (1) confirm that the appellant’s act of charging the RMB 15 yuan value-added cable service fee was invalid, (2) order the return of RMB 15 yuan, and (3) order that Shaanxi pay the plaintiff’s litigation fees. Read More
On Dec. 19, 2013, the Standardization Administration of China (SAC) and State Intellectual Property Office (SIPO) published the Administrative Regulation on National Standards Involving Patents-Interim (Interim Regulations), which concerns the formulation and implementation of national standards involving patents. The Interim Regulations were effective Jan. 1, 2014.
According to the Interim Regulations, national standards involving patents should concern patents that are essential for implementation of the relevant standards. The Interim Regulations impose obligations regarding the disclosure of essential patents that a party owns or knows about. A party that fails to make the required disclosures may be held legally responsible for the failure to do so. In addition, even parties not participating in the formation or revision of national standards are encouraged to disclose essential patents they own or of which they are aware. Read More
On Jan. 9, 2014, three marine transport companies individually announced that the Japan Fair Trade Commission (JFTC) has sent them an advance notice of a surcharge payment order and a cease and desist order, in connection with the agency’s investigation into alleged price fixing on automobile shipments from Japan to North America and Europe. The companies are Nippon Yusen Kabushiki Kaisha, Kawasaki Kisen Kaisha, Ltd. and Wallenius Wilhelmsen Logistics. The JFTC has also reportedly sent such advance notice to Nissan Motor Car Carrier Co., Ltd., although the company has not made any official announcement yet. Mitsui O.S.K. Lines, Ltd., the parent company of Nissan Motor Car Carrier Co., Ltd., also was investigated by the JFTC, but it applied for leniency and avoided receiving the advance notices. Each company will have an opportunity to respond to the notices before the JFTC officially announces its decision. The total amount of fines likely will be about 22 billion JPY ($220 million), which is the second-highest penalty imposed by the JFTC in a single case. Although the three companies disclosed that they received these orders, the JFTC itself has not yet issued any official announcement regarding the orders.
On Dec. 23, 2013, the Korea Fair Trade Commission (KFTC) announced that it imposed fines on foreign auto parts manufacturers and their Korean subsidiaries, in aggregate amounts of 114.6 billion Korean won ($109.1 million), for fixing prices on windshield wipers and instrument panel clusters. The companies fined were Denso Korea Electronics, Denso Korea Automotive, Continental Automotive Electronics and Bosch Electrical Devices. The KFTC noted that Denso Corp., the parent company of the two Denso entities in Korea, also was involved, but it was not fined because it does not have any revenue in Korea.
According to the KFTC, Denso Corp., Denso Korea Electronics and Continental Automotive Electronics colluded to restrict competition and secure certain profit levels when they made bids to supply instrument panel clusters to Hyundai Motor Company and Kia Motors, during the period from January 2008 to March 2012. The KFTC said that Denso Corp., Denso Korea Automotive and Bosch Electrical Devices colluded in making bids to supply such products to Hyundai and Kia during the period from August 2008 to February 2009. Read More
On Nov. 21, 2013, the Beijing No. 2 Intermediate Court issued a ruling in favor of a plaintiff against Beijing Seafood Wholesale Industry Association (“the Association”) in a private action alleging that certain rules of the Association are invalid under the Anti-Monopoly Law. The court ordered the Association to cease organizing its members to reach monopolistic agreements by adjusting and fixing the price of scallops produced by Dalian Zhangzi Island Group Company Limited (“Zhangzi Island Company”).
Certain rules of the Association prohibited its members from participating in unfair competition or refusing to sell scallops at the price fixed by the Association. Members also were prohibited from selling whole scallops to non-members in markets in which the Association’s members participated. A member’s violation of these rules would subject it to a fine of RMB 10,000 ($1,640) for each violation.
A seafood seller in Beijing, who also is a member of the Association, filed a lawsuit against the group, claiming that the rules setting prices for Zhangzi Island scallops and the rules prohibiting members from selling whole scallops to non-members violate the Anti-Monopoly Law. The seafood seller requested a ruling to confirm that the rules are invalid, to order the Association to cease engaging in the conduct, and also to receive economic compensation. The Association argued that it organized its members to fix and adjust the prices based on the requirements of Zhangzi Island Company, and that the Association’s members could determine their prices based on the minimum price. It argued that the purpose of the prohibition on selling whole scallops to non-members was to prevent members from selling across different areas.
The Beijing No. 2 Intermediate Court ruled that: (1) the Association intended to control the market by organizing its members to reach agreements on fixing and adjusting the price of Zhangzi Island scallops; this prevented competition among the members of the Association and caused members to jointly resist competition from non-members; this impacted the normal fluctuation of prices, harmed consumers, and excluded and restricted competition; (2) by prohibiting members from selling whole scallops to non-members, the Association increased the operation costs of non-members and harmed consumers; (3) the Association’s rules fixed commodity prices, which violates the Anti-Monopoly Law. The court reached a verdict in favor of the seafood seller, and a report on the decision is available here. The Association has filed an appeal.
On Oct. 31, 2013, Japan’s Ministry of Economy, Trade and Industry (METI) submitted a brief in support of the defendants in one of the TFT-LCD Flat Panel Antitrust Litigation cases, requesting the U.S. District Court for the Eastern District of Illinois to reconsider a ruling of the U.S. District Court for the Northern District of California, which held that the U.S. Foreign Trade Antitrust Improvement Act (FTAIA) did not preclude U.S. liability for sales of price-fixed LCD panels that never entered the United States.
Motorola sued a number of Korean, Taiwanese and Japanese manufacturers, alleging that they participated in an international price-fixing conspiracy for LCD panels. The case was filed in federal court in Illinois but was transferred for pre-trial purposes to the multidistrict litigation in the Northern District of California. Defendants sought summary judgment with respect to purchases by Motorola’s non-U.S. subsidiaries of LCD panels and products containing them that never entered the United States. The MDL court denied the motion on the ground that some of the negotiations to purchase the panels took place in the United States, and they therefore had a direct and reasonably foreseeable effect on U.S. commerce. The case was remanded to the district court in Illinois for trial, and defendants asked the Illinois court to reconsider the MDL court’s order. The Illinois court decided to accept briefing from the defendants.
METI filed an amicus brief in support of defendants’ position that the FTAIA blocked Motorola’s claims based on LCD panels that never entered the United States. The brief METI submitted was a copy of the same brief it submitted in F. Hoffmann-La Roche, LTD. v. Empagran S.A., 542 U.S. 155 (2004), the U.S. Supreme Court’s seminal decision explaining the scope and contours of the FTAIA. METI’s brief argues that the FTAIA “should not be interpreted to allow foreign purchasers of goods from foreign corporations in foreign markets to bring actions in the United States courts for alleged injuries under United States antitrust laws. … Giving foreign purchasers the right to damages for purely foreign market transactions undermines the important principles of comity, respect due to a sovereign nation to regulate conduct within its own national territory. Such an interpretation of the FTAIA has international public policy implications which would adversely affect the ability of the government of Japan to regulate its own economy and govern its own society.”
It is unusual for METI to submit amicus briefs in proceedings in the United States, so its resubmission of its brief in the Empagran case demonstrates a strong interest in protecting Japanese companies from the application of the U.S. antitrust laws to conduct that takes place outside the United States and which does not affect products imported into the United States.
On Aug. 7, 2013, the National Development and Reform Commission (NDRC) issued fines totaling around $110 million to six producers of baby formula (namely Danone, Mead Johnson, Fonterra, Abbott, FrieslandCampina and Biostime) for price-fixing and anti-competitive behavior.
As a percentage of Chinese revenues, the harshest fine was imposed on Biostime (the only Chinese company involved), for an amount of RMB 162.9 million (approximately 6 percent of Biostime’s revenues in the previous year). Mead Johnson was handed a fine equal to 4 percent of its annual sales revenues in China, while the other three companies’ fines were set at about 3 percent of revenues.
Collectively, these constitute the largest fine ever imposed by the NDRC and reflect the varying levels, among the respective participants, of cooperation with the authorities and corrective action taken in response to the investigation. Three other companies (Nestle, Beingmate and Meiji) were granted full immunity for cooperating with NDRC, providing information to the investigators and proactively implementing measures to rectify any breaches.
On Sept. 13, 2013, the head of the South Korean antitrust regulator (the Korea Fair Trade Commission) announced a strengthening of the penalties for unfair business activities. This announcement comes following accusations of excessive leniency being granted by the KFTC when imposing a reduced penalty of $8,300 on a brewery found to have engaged in abusive behavior.
The KFTC stated that the original fine imposed on Baesangmyun Brewery, which had forced wholesalers to purchase more products than they required in order to reduce its unsold inventory, was reduced because the company had reported recent consecutive annual losses and had shown a high degree of cooperation with authorities during the course of the investigation.
The KFTC explained that the current rules on penalties will be revised by the end of the year, with enforcement to start in 2014.
Until this year, China’s enforcement activities in the field of antitrust, particularly as these activities have affected foreign companies, had been mainly focused on merger control with merger filings handled by the Anti-Monopoly Bureau of the Ministry of Commerce (MOFCOM). Other areas of competition law such as resale price maintenance, price fixing, cartels and abuse of dominance, although addressed under China’s Anti-Monopoly Law (AML), had received scant attention from domestic and foreign companies, and the relevant regulatory bodies had taken few if any steps to enforce the relevant provisions of the AML. By way of example, until this year, an investigation into proposed price increases by Unilever in 2011, which resulted in a RMB 2 million (US$318,000) fine for Unilever, had been China’s only investigation of a multinational company related to pricing issues, and this investigation was carried out under the provisions of China’s Price Law, which dates from 1997.
Widening the scope of enforcement activities
For some time now, there have been signs that this limited focus is changing. Last year, both the National Development and Reform Commission (NDRC)—the body responsible for enforcing the price-related provisions of the AML—and the State Administration for Industry and Commerce (SAIC)—responsible for the enforcement of non-price-related provisions of the AML—expanded their antitrust teams in a move widely seen as a precursor of increased enforcement activities. In addition, the Supreme People’s Court (SPC) published the Provisions on Several Issues Concerning the Application of the Law in Trials of Civil Dispute Cases Arising from Monopolistic Acts (see previous Newsletter coverage here) with the apparent intention of encouraging the private enforcement of the provisions of the AML in the Chinese courts.
The first half of 2013 has seen a notable increase in the scope of enforcement of China’s AML and the involvement of regulatory bodies other than MOFCOM. There were several high-profile court cases addressing complex antitrust issues. We highlight some of the most important developments below. Read More
China’s antitrust pricing regulator, the National Development and Reform Commission (NDRC), is investigating alleged price fixing and anticompetitive practices by international producers of infant milk formula following concerns about high prices for consumers. The concerns were triggered by complaints from domestic producers of infant milk formula whose market share has dropped after a string of high-profile food safety scandals affecting domestic brands. China’s official Communist Party newspaper, the People’s Daily, published an article stating that foreign and local players are equal before the law but that foreign brands should not raise prices frequently without regard to the law or abuse their competitive advantage. The investigation is believed to focus on the relationships between manufacturers, distributors and retailers and to cover attempts by the producers to require retailers not to sell their products below a certain minimum price. However, the regulator has published very little information about the investigation. Some of the companies involved in the investigation have issued statements stating that they are cutting their prices in China and/or reviewing their distribution arrangements.
China’s National Development and Reform Commission (NDRC) has launched a wide-ranging investigation into the costs of medicines in China amid concerns about discriminatory pricing and abuse of intellectual property rights. The investigation is not a surprise and there had been indications that the sector would be investigated this year. The regulator has previously expressed concerns about the pharmaceutical sector. In November 2012, the deputy director general of the Bureau of Price Supervision and Antimonopoly at the NDRC stated that some companies were abusing their dominance by monopolizing the materials needed for drugs and Chinese herbal medicine. A month later, the director general of the Bureau told an audience at a competition law conference that pharmaceutical companies were “over-protected” by patents and suggested that this created the potential for anticompetitive behavior. The sector has also been investigated in the past in China. However, this appears to mark the first time overseas pharmaceutical companies have been investigated. There has been no indication whether the NDRC will announce an official investigation of the sector or of particular companies, nor is it known how long the probe might last.
China’s national market regulatory agency, the State Administration for Industry and Commerce, has announced that it is investigating possible abuse of dominance by Tetra Pak. According to statements by the SAIC, more than 20 provincial and municipal level AICs are assisting in the investigation. The regulators have requested that Tetra Pak provide information relating to its China operations. This is the first time the SAIC has been involved in a major, high-profile antitrust investigation and it should provide some indication of what to expect from the SAIC as an antitrust regulator.
The China Council for the Promotion of International Trade (CCPIT), Nantong Sub-Council—a state-affiliated trade association—is recruiting qualified Chinese freight forwarders and trading companies from the city of Nantong to participate in the case of Emerald Supplies Limited & Southern Glasshouse Produce Limited v. British Airways Plc. The intention is to pressure British Airways and other defendants to enter settlement and compensation agreements. According to information published on the Sub-Council’s website, CCPIT has been coordinating with companies from all parts of the country to participate in the lawsuit. The Sub-Council also stated that the number of Chinese companies affected was large and that the amount of the losses is huge.